Navigation Links
REOLYSIN in Medical News

Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells

...id neurosurgeon John S. Yu, M.D., director of Surgical Neuro-oncology at Cedars-Sinais Department of Neurosurgery. Yu is principal investigator of the reolysin clinical trial at Cedars-Sinai. According to the protocol of this open-label Phase I and II trial, patients will receive a single treatment of REO...

Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials

...terim results from a U.K. Phase Ia/Ib combination reolysin and radiation clinical trial for patients with adv...the trial received two intratumoural treatments of reolysin at dosages of 1x108, 1x109, or 1x1010 TCID50 with ...ved either two, four or six intratumoural doses of reolysin at 1x1010 TCID50 with a constant localized radiati...

Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs

... investigators examining various co-therapies with reolysin is providing Oncolytics with the rationale for its...fficer at Oncolytics. "This research suggests that reolysin can be combined with many existing therapies that ...he treatment of cancer patients." Currently, reolysin is being used in Phase I and Phase I/II human clin...
REOLYSIN in Medical Technology

Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial

CALGARY, June 05, 2007 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") announced today positive results from its U.S. Phase I clinical trial examining the systemic administration of REOLYSIN(R) in patients with advanced cancers. The results indicate that REOLYSIN(R) can be delivere...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...
REOLYSIN in Biological News

Oncolytics Biotech, Inc. announces publication of research

...appears online in the January 1, 2008 issue of Clinical Cancer Research. This exciting Mayo Clinic work supported the initiation of our combination reolysin and cyclophosphamide clinical trial, recently approved by the U.K. health authorities, said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. ...

Dealing deadly cancers a knockout punch

...melanomas. Recent studies also indicate that reolysin works synergistically with standard anti-cancer dr...ther studies completed in the past year have shown reolysin has the ability to prime patients' immune systems ...ond "inflammatory" mechanism that researchers hope reolysin will bring about long-term remissions of once-untr...
REOLYSIN in Biological Technology

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...ed by our investigators, reinforce our belief that reolysin has the potential to significantly improve treatme...ASCO demonstrating that the combination of reolysin and gemcitabine in a U.K. Phase I trial was well t... - Presented a poster at ASCO that indicated reolysin was well tolerated and demonstrated anti-t...

Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)

...y completed an initial 100-litre production run of reolysin under cGMP conditions. This run is anticipated to ...s, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely comp...

Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)

...the lyophilization process, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

...ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...

Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial

...e Phase II component of a Phase I/II U.K. trial of reolysin combined with paclitaxel/carboplatin for patients ... Phase III pivotal program now being developed for reolysin in combination with carboplatin/paclitaxel for hea...atory Phase II trial using the same combination of reolysin and carboplatin/paclitaxel for patients with head ...

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting

...ntation, entitled "A Phase II Study of Intravenous reolysin (Wild-type Reovirus) in the Treatment of Patients ...es in whom the IDD group are investigating various reolysin regimens," said Dr. Frank Giles, Director, IDD, an... Deputy Director, CTRC at UTHSCSA. Additional reolysin results presented Two additional poster prese...

Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference

...d today that data from three clinical trials using reolysin are scheduled to be presented at the 2009 American...he ASCO website today at www.asco.org . reolysin poster presentations - Dr. Monica Mita and ... I Study of the Combination of Intravenous reolysin (REO) and Gemcitabine (GEM) in Patients (pts) ...

Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study

... antitumour activity of intravenous, multiple dose reolysin in patients with bone and soft tissue sarcomas metastatic to the lung. reolysin is delivered intravenously to patients at a dose o...al and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...

Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results

...l benefit in the majority of patients treated with reolysin in combination with chemotherapy or radiation, pav... results from a U.K. Phase I/II combination reolysin and paclitaxel/carboplatin trial for patients with...Announced positive results from a U.K. combination reolysin and docetaxel trial for patients with a var...

Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting

... results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of phar...
Other Tags
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one ... New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to learn ... at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM ...
(Date:9/4/2015)... ... 2015 , ... After wearing the same uniforms for six seasons, the Sprayberry ... effort to assist the team, the Jones Agency, a locally owned insurance firm that ... for the new uniforms. , As is so often the case with high school ...
(Date:9/4/2015)... ... 2015 , ... A Union County charitable organization will host ... is a non-profit organization dedicated to offering Pilates scholarships to cancer patients to ... recover their mobility, strength, and range of motion following breast cancer surgery. ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Keeping mold ... and around the home is quite common. Mold can grow anywhere - on carpet, ... leaking pipes. Checking for excessive moisture and water in the home is key to ...
(Date:9/4/2015)... ... 04, 2015 , ... “Getting away from the daily stressors and distractions of ... strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort ... island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in ...
Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/5/2015)... , August 5, 2015 Transparency ... "Facial Recognition Market - Global Industry Analysis, Size, Share, ... market for facial recognition is forecast to reach US$ ... increased demand for surveillance systems by civil and government ... of crimes and terrorist activities across the globe that ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
Other Contents